Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | ENO1 | P06733 | 1/20 | 0.43 |
| ▸ | PGK1 | P00558 | 1/20 | 0.43 |
| ▸ | PGK2 | P07205 | 1/20 | 0.43 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | ACE | P12821 | 1/20 | 0.36 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.36 |
| ▸ | PEPD | P12955 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19697647 | 0.77 | TSHR (0.39) | MEN1LMNAHPGDTSHRBLM | |
| Fosfonet SCHEMBL15612 | 0.73 | — | — | |
| Fosfonet SCHEMBL15510455 | 0.71 | MEN1 (0.93) | MEN1LMNAHPGDTSHRBLM | |
| Fosfonet SCHEMBL11026013 | 0.71 | — | — | |
| Fosfonet SCHEMBL26676054 | 0.71 | — | — | |
| Fosfonet SCHEMBL2801407 | 0.71 | — | — | |
| Fosfonet SCHEMBL9162319 | 0.71 | — | — | |
| Fosfonet SCHEMBL26676053 | 0.71 | MEN1 (0.93) | MEN1LMNAHPGDTSHRBLM | |
| Fosfonet SCHEMBL4607410 | 0.71 | MEN1 (0.93) | MEN1LMNAHPGDTSHRBLM | |
| Fosfonet SCHEMBL28151124 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 728 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250282802-A1 | PHOSPHONATE PRODUCTS AND METHODS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2025-09-11 | — | — | US | claimed |
| EP-4605521-A2 | GENETICALLY MODIFIED HOST CELLS PRODUCING L-SERINE | CysBio ApS (DK) | 2025-08-27 | — | — | EP | claimed |
| US-20250215468-A1 | METHOD FOR CONVERTING CARBON SOURCE INTO SERINE | NAN YA PLASTICS CORPORATION (TW) | 2025-07-03 | — | — | US | claimed |
| WO-2025104134-A9 | EXPRESSION OF BIOMOLECULES WITH IMPROVED PROMOTER AND TIR | CYSBIO APS (DK) | 2025-06-19 | — | — | WO | claimed |
| WO-2025104134-A2 | EXPRESSION OF BIOMOLECULES WITH IMPROVED PROMOTER AND TIR | CYSBIO APS (DK) | 2025-05-22 | — | — | WO | claimed |
| EP-4556561-A1 | EXPRESSION OF BIOMOLECULES WITH IMPROVED PROMOTER AND TIR | CysBio ApS (DK) | 2025-05-21 | — | — | EP | claimed |
| CN-120005781-A | Expression of biomolecules with improved promoters and TIR | 赛斯生物私人有限公司 | 2025-05-16 | — | — | CN | claimed |
| US-20240391961-A1 | AUTONOMOUS ORGANISMS FOR SYNTHESIS OF PERMANENTLY PHOSPHORYLATED PROTEINS | OREGON STATE UNIVERSITY (US) | 2024-11-28 | — | — | US | claimed |
| CN-118834862-A | Method for synthesizing phosphonoacetaldehyde by enzymatic method | 中国科学院大学 | 2024-10-25 | — | — | CN | claimed |
| CN-118725325-A | Method for improving freezing resistance of metal-organic framework and application of method in erythrocyte freezing protection | 华南理工大学 | 2024-10-01 | — | — | CN | claimed |
| US-8494779-B2 | Method for screening essential metabolites in growth of microorganisms | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2013-07-23 | — | — | US | claimed |
| US-20130109067-A1 | METHOD FOR THE PREPARATION OF HYDROXY ACIDS | METABOLIC EXPLORER | 2013-05-02 | — | — | US | claimed |
| US-20110244575-A1 | METHODS, SYSTEMS AND COMPOSITIONS FOR INCREASED MICROORGANISM TOLERANCE TO AND PRODUCTION OF 3-HYDROXYPROPIONIC ACID (3-HP) | OPX BIOTECHNOLOGIES, INC. | 2011-10-06 | — | — | US | claimed |
| US-20100143911-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2010-06-10 | — | — | US | claimed |
| CN-101611312-A | Method for screening essential metabolites in microbial growth | KOREA INST SCI & TECH (KR) | 2009-12-23 | — | — | CN | claimed |
| EP-2097743-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | Korea Advanced Institute of Science and Technology (KR) | 2009-09-09 | — | — | EP | claimed |
| WO-2008078911-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2008-07-03 | — | — | WO | claimed |
| WO-2001077366-A1 | POSITIVE SELECTION METHOD, COMPOUNDS, HOST CELLS AND USES THEREOF | CUBIST PHARMACEUTICALS, INC. (US) | 2001-10-18 | — | — | WO | claimed |
| EP-0258290-A1 | METHOD AND ADDITIVES FOR IMPROVING THE QUALITY AND SHELF LIFE OF STORED BLOOD | VORA, Shobhana (US) | 1988-03-09 | — | — | EP | claimed |
| WO-1987004072-A1 | METHOD AND ADDITIVES FOR IMPROVING THE QUALITY AND SHELF LIFE OF STORED BLOOD | VORA SHOBHANA (US) | 1987-07-16 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250282802-A1 | PHOSPHONATE PRODUCTS AND METHODS | CHAMP1, PHOSPHO1, RIOX2 | MEN1 1665/4885LMNA 1915/4885HPGD 699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.